6
2012.
Monitoring of disease biomarkers activity and immunophenotyping as important factors in SLE clinical management.
Monitoring of disease biomarkers activity and immunophenotyping as important factors in SLE clinical management.
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više